Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro

British Journal of Rheumatology

Volumn 37, Issue 1, 1998, Pages 64-70

  Tetlow, L C ^a   Woolley, D E ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Chondrocytes; Collagenase 1; Collagenase 3; Immunolocalization; Rheumatoid lesion; Synoviocytes

Indexed keywords

COLLAGENASE; INTERLEUKIN 1BETA;

ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; KNEE ARTHROPLASTY; MALE; PRIORITY JOURNAL; SYNOVIOCYTE;

EID: 0031823324     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.1.64     Document Type: Article

References (28)

1. Martel Pelletier J, Pelletier J-P. Wanted, the collagenase responsible for the destruction of the collagen network in human cartilage. Br J Rheumatol 1996;35:818-20.
2. Cole AA, Kuettner KE. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage. Acta Orthop Scand 1995;66:98-102.
3. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 1996;97:2011-9.
4. Mitchell PG, Magna HA, Reeves LM et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
5. Borden P, Solymer D, Sucharczuk A et al. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J Biol Chem 1996;271:23577-81.
6. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
7. Knauper V, Will H, Lopez-Otin C et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J Biol Chem 1996;271:17124-31.
8. Woolley DE, Crossley MJ, Evanson JM. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum 1977;20:1231-9.
9. Freije JMP, Diez-Itza I, Balbin M et al. Molecular cloning and expression of collagenase-3 a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
10. Vaalamo M, Johansson N, Westermarck J, Kahari V-M, Saarialho-Kere U. Collagenase 3 is expressed by stromal cells in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1996;107:517.
11. Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996;23:590-5.
12. Meats JE, McGuire MK, Russel RGG. Human synovium releases a factor which stimulates chondrocyte production of PGE and plasminogen activator. Nature 1980;286:891-2.
13. Tetlow LC, Lees M, Ogata Y, Nagase H, Woolley DE. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 1993;13:53-9.
14. Tetlow LC, Lees M, Woolley DE. Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro. Virchows Archiv 1995;425: 569-76.
15. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase (pMMP-1) and stromelysin (pMMP-3) but not gelatinases A and B (pMMP-2 and pMMP-9). Eur J Biochem 1994; 223:171-7.
16. Birkedal-Hansen H, Moore WGI, Bodden MK et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
17. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Immunolocalisation studies on six metallo-proteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 1995;54:25-32.
18. Gravellese EM, Darling JM, Ladd AI, Katz JN, Glimcher LH. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-84.
19. Firestein GS, Paine MM. Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 1992;140:1309-14.
20. Tetlow LC, Woolley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995;54: 896-903.
21. Fosang AJ, Last K, Knauper V, Murphy G, Neame P. Degradation of cartilage aggrecan by collagenase 3 (MMP-13). FEBS Lett 1996;380:17-20.
22. Woolley DE, Lindberg KA, Glanville RW, Evanson JM. Action of rheumatoid synovial collagenase on cartilage collagen. Different susceptibilities of cartilage and tendon collagen to collagenase attack. Eur J Biochem 1975;50:437-44.
23. Caron JP, Tardif G, Martel-Pelletier J, DiBattista JA, Geng C. Modulation of matrix metalloproteinase 13 (collagenase 3) gene expression in equine chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res 1996;57:1631-4.
24. Martel-Pelletier J, Moldovan F, Hambor J, Cloutier J-M, Pelletier J-P. Preferential in vivo localisation of collagenase 3 in the deeper zone of human arthritic cartilage. Arthritis Rheum 1996;39(9ss):1104.
25. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984;27:857-63.
26. Mohr W. Pathobiochemistry of cartilage destruction. J Clin Chem Clin Biochem 1986;24:949-51.
27. Woolley DE, Tetlow LC. Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis. Ann Rheum Dis 1997;56:151-61.
28. Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, Lopez-Otin C. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997;40:1391-9.